235 related articles for article (PubMed ID: 22057994)
21. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
Du J; Wang X; Tan G; Wei W; Zhou F; Liang Z; Li H; Yu H
J Mol Med (Berl); 2021 Oct; 99(10):1487-1495. PubMed ID: 34287665
[TBL] [Abstract][Full Text] [Related]
22. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.
Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K
Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881
[TBL] [Abstract][Full Text] [Related]
23. HLA-DRB1*03 is a susceptibility gene in patients with Graves' disease with and without ophthalmopathy.
Yarman S; Oguz F; Carin M
Int J Immunogenet; 2007 Feb; 34(1):23-5. PubMed ID: 17284224
[TBL] [Abstract][Full Text] [Related]
24. Genetic variants of BANK1 gene in autoimmune thyroid diseases: a case-control association study.
Muhali FS; Song RH; Wang X; Shi XH; Jiang WJ; Xiao L; Li DF; He ST; Xu J; Zhang JA
Exp Clin Endocrinol Diabetes; 2013 Oct; 121(9):556-60. PubMed ID: 24127308
[TBL] [Abstract][Full Text] [Related]
25. Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist.
Khalilzadeh O; Anvari M; Esteghamati A; Mahmoudi M; Tahvildari M; Rashidi A; Khosravi F; Amirzargar A
Clin Exp Ophthalmol; 2009 Aug; 37(6):614-9. PubMed ID: 19702713
[TBL] [Abstract][Full Text] [Related]
26. Graves' disease in Brazilian children and adults: lack of genetic association with CTLA-4 +49A>G polymorphism.
Namo Cury A; Longui CA; Kochi C; Calliari LE; Scalissi N; Salles JE; Neves Rocha M; Barbosa de Melo M; Rezende Melo M; Monte O
Horm Res; 2008; 70(1):36-41. PubMed ID: 18493148
[TBL] [Abstract][Full Text] [Related]
27. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.
Esteghamati A; Khalilzadeh O; Mobarra Z; Anvari M; Tahvildari M; Amiri HM; Rashidi A; Solgi G; Parivar K; Nikbin B; Amirzargar A
Eur J Intern Med; 2009 Jul; 20(4):424-8. PubMed ID: 19524188
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1beta gene (IL-1beta) polymorphisms (SNP -511 and SNP +3953) in thyroid-associated ophthalmopathy (TAO) among the Polish population.
Lacka K; Paradowska A; Gasinska T; Soszynska J; Wichary H; Kramer L; Lacki JK
Curr Eye Res; 2009 Mar; 34(3):215-20. PubMed ID: 19274529
[TBL] [Abstract][Full Text] [Related]
29. The common -318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients.
Han SZ; Zhang SH; Li R; Zhang WY; Li Y
Int J Immunogenet; 2006 Aug; 33(4):281-7. PubMed ID: 16893393
[TBL] [Abstract][Full Text] [Related]
30. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children.
Chong KK; Chiang SW; Wong GW; Tam PO; Ng TK; Hu YJ; Yam GH; Lam DS; Pang CP
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2409-15. PubMed ID: 18296657
[TBL] [Abstract][Full Text] [Related]
31. Genetic association between IL-17F gene polymorphisms and the pathogenesis of Graves' Disease in the Han Chinese population.
Guo T; Huo Y; Zhu W; Xu F; Liu C; Liu N; Cao M; Cui B; Ning G
Gene; 2013 Jan; 512(2):300-4. PubMed ID: 23111159
[TBL] [Abstract][Full Text] [Related]
32. Lack of association between pro-inflammatory cytokine (IL-6, IL-8 and TNF-alpha) gene polymorphisms and Graves' disease.
Chen RH; Chen WC; Wang TY; Tsai CH; Tsai FJ
Int J Immunogenet; 2005 Dec; 32(6):343-7. PubMed ID: 16313297
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of DNA base-excision repair genes APE/Ref-1 and XRCC1 are not associated with the risk for Graves' disease.
Doğru-Abbasoğlu S; Tanrikulu S; Ademoğlu E; Erbil Y; Ozderya A; Karadağ B; Uysal M
Cell Biochem Funct; 2009 Oct; 27(7):462-7. PubMed ID: 19711438
[TBL] [Abstract][Full Text] [Related]
34. The Role of
Yaylacıoğlu Tuncay F; Serbest Ceylanoğlu K; Güntekin Ergün S; Ergün G; Konuk O
Turk J Ophthalmol; 2024 Apr; 54(2):69-75. PubMed ID: 38645270
[TBL] [Abstract][Full Text] [Related]
35. CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region.
Frydecka I; Daroszewski J; Suwalska K; Zołedziowska M; Tutak A; Słowik M; Potoczek S; Dobosz T
Arch Immunol Ther Exp (Warsz); 2004; 52(5):369-74. PubMed ID: 15507878
[TBL] [Abstract][Full Text] [Related]
36. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Davies TF
Thyroid; 2012 Jul; 22(7):730-6. PubMed ID: 22663548
[TBL] [Abstract][Full Text] [Related]
37. Lack of association of IRF5 gene polymorphisms with autoimmune thyroid disease: a case-control study. IRF5 gene and AITD.
Muhali FS; Zhou-jiao Z; Wang Y; Wang Q; Shi XH; Jiang WJ; Xiao L; Li DF; He ST; Xu J; Zhang JA
Ann Endocrinol (Paris); 2014 Feb; 75(1):19-24. PubMed ID: 24582590
[TBL] [Abstract][Full Text] [Related]
38. Association of PARP-1, NF-κB, NF-κBIA and IL-6, IL-1β and TNF-α with Graves Disease and Graves Ophthalmopathy.
Niyazoglu M; Baykara O; Koc A; Aydoğdu P; Onaran I; Dellal FD; Tasan E; Sultuybek GK
Gene; 2014 Sep; 547(2):226-32. PubMed ID: 24956560
[TBL] [Abstract][Full Text] [Related]
39. beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease.
Jazdzewski K; Bednarczuk T; Stepnowska M; Liyanarachchi S; Suchecka-Rachon K; Limon J; Narkiewicz K
Int J Mol Med; 2007 Jan; 19(1):181-6. PubMed ID: 17143563
[TBL] [Abstract][Full Text] [Related]
40. TNF gene polymorphisms in Graves' disease: TNF-308 A/G meta-analysis.
Kammoun-Krichen M; Bougacha-Elleuch N; Rebai A; Mnif M; Abid M; Ayadi H
Ann Hum Biol; 2008; 35(6):656-61. PubMed ID: 18989801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
